Toll‐like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β–Dependent Fibroblast Activation
Feng Fang(Northwestern University), John Varga(Michigan Medicine), Wenjie Qin(China Three Gorges University), Warren G. Tourtellotte(Cedars-Sinai Medical Center), Anna Shangguang(Northwestern University), Yang Yang(Purdue University West Lafayette), Jun Wei(Northwestern University), Wenxia Wang(Sun Yat-sen University), Swati Bhattacharyya(University of Michigan), Roberta Gonçalves Marangoni(Ospedale Santa Maria della Misericordia di Rovigo), Xingchun Zhou(China Pharmaceutical University), Boping Ye(China Pharmaceutical University)
Cited by 67
Related Papers
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
|Science|1995|1.5k
Systemic sclerosis: a prototypic multisystem fibrotic disorder
|Journal of Clinical Investigation|2007|1.1k
The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience
|Trends in Neurosciences|1999|461
Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation
|Immunity|2021|409
Myofibroblasts in Murine Cutaneous Fibrosis Originate From Adiponectin‐Positive Intradermal Progenitors
|Arthritis & Rheumatology|2014|334